Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NEOATRICON 4,5 MG/ML SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/NEOATRICON 4,5 MG/ML SOLUCION PARA PERFUSION

Approved

STANDARD

NEOATRICON 4,5 MG/ML SOLUCION PARA PERFUSION

Brepco Biopharma Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 9, 2025
Approval ID: 58bd028d9da677b6
Company: Brepco Biopharma Limited
Type: Standard

Approval Details

Approval Id: 58bd028d9da677b6
Drug Cima Aemps Name: NEOATRICON 4,5 MG/ML SOLUCION PARA PERFUSION
Register Number: 1241804002
Holder Company Name: Brepco Biopharma Limited
Marketing Company Name: Euromed Pharma Spain S.L.
Holder Company Detail Path: /organization/8dffd66505614f49/brepco-biopharma-limited
Authorization Date: 2025-04-09
Dosage Form: SOLUCIÓN PARA PERFUSIÓN
Dose: 4,5 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Brepco Biopharma Limited
Company Detail Path: /organization/8dffd66505614f49/brepco-biopharma-limited

Company Information

Pharmaceutical Company Name: BREPCO BIOPHARMA LIMITED
Country Name: Ireland
City Name: dublin,country_ie
Address: SUITE ONE THE AVENUE BEACON COUR

Active Ingredients

DOPAMINA HIDROCLORURO

225 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 9, 2025

Approval ID

58bd028d9da677b6

Type

Standard

Back to CIMA-AEMPS Approvals